FGFR2 and cholangiocarcinoma: Furthermore, Viganò et al. [32] introduced a CT-based radiogenomic model that non-invasively predicts genetic alterations in intrahepatic CCA, achieving an AUC of 0.819 for IDH1 mutations and 0.892 for FGFR2 alterations.